These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7361234)

  • 1. A clinical and bacteriologic evaluation of cefamandole therapy in serious skin and skin structure infections.
    Glanges E; Crenshaw CA; Webber CE
    Surg Gynecol Obstet; 1980 Apr; 150(4):502-6. PubMed ID: 7361234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of serious skin and soft tissue infections with cefamandole.
    Glanges E; Webber CE; Crenshaw CA; Pasquet M; Barksdale L
    Scand J Infect Dis Suppl; 1980; suppl 25():69-74. PubMed ID: 7010539
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefamandole in the treatment of serious bone and joint diseases.
    Levine LR
    Scand J Infect Dis Suppl; 1980; suppl 25():89-93. PubMed ID: 7010542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pediatric experiences with cefamandole nafate].
    Perinotto G; Belloni CL; Robecchi GA; Fiorella G
    Clin Ter; 1981 Apr; 97(2):165-74. PubMed ID: 7237956
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftizoxime treatment of cutaneous and subcutaneous tissue infections.
    Parish LC; Parks DB; Layne PP; Uri JV
    Clin Ther; 1984; 6(5):613-9. PubMed ID: 6090019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefamandole for treatment of obstetrical and gynecological infections.
    Cunningham FG; Gilstrap LC; Kappus SS
    Scand J Infect Dis Suppl; 1980; suppl 25():75-82. PubMed ID: 7010540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefamandole in the treatment of infections due to Enterobacter and indole-positive Proteus.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S125-S132. PubMed ID: 649997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of prophylactic cefamandole in extended gynecologic surgery.
    Creasman WT; Hill GB; Weed JC; Gall SA
    Obstet Gynecol; 1982 Mar; 59(3):309-14. PubMed ID: 7043340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of cefpodoxime proxetil in patients with dermatological infections.
    Imaizumi T; Ishikawa H; Hashimoto I
    J Chemother; 1995 Nov; 7 Suppl 4():137-41. PubMed ID: 8904135
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of serious anaerobic infections.
    Greenberg RN; Scalcini MC; Sanders CV; Lewis AC
    Scand J Infect Dis Suppl; 1980; suppl 25():84-8. PubMed ID: 7010541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, double blind study of preventive cefamandole therapy in patients at high risk for undergoing cholecystectomy.
    Crenshaw CA; Glanges E; Webber CE; McReynolds DB
    Surg Gynecol Obstet; 1981 Oct; 153(4):546-52. PubMed ID: 7025307
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cefamandole as prophylactic A.B. in abdominal surgery. Comparative study of cefamandole versus clindamycin/tobramycin (author's transl)].
    Iarchy J
    Acta Chir Belg; 1980; 79(5):321-6. PubMed ID: 7223262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
    Terui T; Tagami H
    J Chemother; 1995 Nov; 7 Suppl 4():119-21. PubMed ID: 8904129
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of cefamandole and cefazolin during cardiopulmonary bypass.
    Bryan CS; Smith CW; Sutton JP; Allen WB; Blanding R; Gangemi JD
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):222-5. PubMed ID: 6348425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of antibiotics on infection in spinal surgery: a prospective study of 110 patients.
    Wimmer C; Nogler M; Frischhut B
    J Spinal Disord; 1998 Dec; 11(6):498-500. PubMed ID: 9884294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial peritonitis. Protecting the high-risk patient.
    Jones LM; Miller S
    Am Surg; 1984 Jul; 50(7):358-61. PubMed ID: 6378000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cephamandole--pharmacokinetic, pharmacodynamic and clinical examinations (author's transl)].
    Car V; Schönwald S; Lenardic A; Gmajnicki B; Falisevac J
    Lijec Vjesn; 1979 Jun; 101(6):371-4. PubMed ID: 502719
    [No Abstract]   [Full Text] [Related]  

  • 18. Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
    Perkins RL; Fass RJ; Warner JF; Prior RB; File TM; Tight RR; Gardner WG; Ruiz DE; Slama TG
    J Infect Dis; 1978 May; 137 Suppl():S110-S118. PubMed ID: 418126
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefamandole therapy in hand infections.
    Robson MC; Schmidt D; Heggers JP
    J Hand Surg Am; 1983 Sep; 8(5 Pt 1):560-2. PubMed ID: 6415153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.